Skin Laxity Clinical Trial
Official title:
A Single Center, Blinded, Split-Body, Randomized Clinical Trial of High Intensity Ultrasound for the Treatment of Upper Inner Arm Skin Laxity
Upper inner arms of enrolled subjects will be randomized to two (2) treatment groups: Sofwave and Ultherapy, with subjects receiving treatment with one device on their right side and the other on their left.
Status | Recruiting |
Enrollment | 15 |
Est. completion date | October 1, 2023 |
Est. primary completion date | April 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 35 Years to 70 Years |
Eligibility | Inclusion Criteria: a) Male or female subjects > 35 years of age and < 70 years of age b) Subjects in good general health based on investigator's judgment and medical history c) Upper inner arm skin laxity that improves when the skin of the upper inner arm is stretched or lifted superiorly d) Moderate to severe upper inner arm skin crepiness/laxity based on the Upper Inner Arm Visual Crepiness/Laxity Grading Scale (Appendix B) e) Must be willing to give and sign an informed consent form and photographic release form f) Must have a stable body weight for at least six (6) months prior to study entry g) Must be willing to maintain usual sun exposure, diet, and exercise routines for the duration of the study h) Must agree to avoid tanning or use of sunless tanner during the entire course of the study i) Negative urine pregnancy test result at the time of study entry (if applicable) j) For female subjects of childbearing potential, must be willing to use an acceptable form of birth control during the entire course of the study. All systemic birth control measures must be in consistent use for at least 30 days prior to study enrollment. 1. A female is considered of childbearing potential unless she is postmenopausal, without a uterus and/or both ovaries, or has had a bilateral tubal ligation. 2. Acceptable methods of birth control are: oral contraceptives, contraceptive patches/rings/implants, Implanon®, Depo-Provera®, double-barrier methods (e.g., condoms and spermicide), abstinence, and/or vasectomy of partner with a documented second acceptable method of birth control, should the subject become sexually active. k) Must be willing to comply with study treatments and complete the entire course of the study Exclusion Criteria: 1. Liposuction to bilateral upper arms during the 12-month period prior to study treatment or any time during the course of the study 2. Mesotherapy; dermal fillers, biostimulatory injectables; radiofrequency device treatments; microfocused ultrasound device treatments; laser and light-based device treatments; microneedling; cryolipolysis; high intensity focused electromagnetic energy device treatment; or surgery (i.e., brachyplasty) during the 12-month period before study treatment 3. Any investigational treatment of skin crepiness/laxity of the upper arms during the 12-month period before the study treatment 4. Creams/cosmeceuticals and/or home therapies to prevent or treat skin laxity during the four-week period before study treatment 5. Subjects with scarring in the treatment areas 6. History of thrombosis, post-thrombosis syndrome, or any vascular disorder of the bilateral upper extremities 7. Any history of bleeding or coagulation disorders 8. Subjects with tattoos or permanent implants in the treatment areas 9. Subjects with a significant history or current evidence of a medical, psychological, or other disorder that, in the investigator's opinion, would preclude enrollment into the study 10. Subjects with a history of or presence of any skin condition/disease (including but not limited to any visible rash, atopic dermatitis, psoriasis, actinic keratoses, keratinocyte carcinoma, melanoma, etc.) in the treatment area that might interfere with the diagnosis or evaluation of study parameters 11. Subjects with an active bacterial, viral, or fungal infection of the treatment areas 12. Subjects who spray tanned or used sunless tanners in the treatment areas four (4) weeks prior to study treatment 13. History of lidocaine sensitivity deemed by the investigator to preclude the subject from enrolling into the study 14. Subjects planning any cosmetic procedure to the treatment areas during the study period, other than the treatment that will be performed by the investigator 15. Presence of incompletely healed wound(s) in the treatment area 16. Subject who is on an immunosuppressant or has an autoimmune condition 17. Female subjects who are pregnant, planning a pregnancy, or breast feeding during the study 18. Current participation or participation within 30 days prior to the start of this study in a drug or other investigational research study |
Country | Name | City | State |
---|---|---|---|
United States | Cosmetic Laser Dermatology | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
Goldman, Butterwick, Fitzpatrick and Groff | Sofwave Medical LTD |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Upper Inner Arm Visual Skin Crepiness and Laxity | Upper Inner Arm Visual Skin Crepiness/Laxity Grading Scale completed by blinded investigator | Screening to One Month Post-Treatment | |
Primary | Upper Inner Arm Visual Skin Crepiness and Laxity | Upper Inner Arm Visual Skin Crepiness/Laxity Grading Scale completed by blinded investigator | Screening to Three Months Post-Treatment | |
Primary | Upper Arm Circumference | Blinded Investigator Measurement of Point of Maximal Upper Arm Skin Laxity and Circumference | Screening to One Month Post-Treatment | |
Primary | Upper Arm Circumference | Blinded Investigator Measurement of Point of Maximal Upper Arm Skin Laxity and Circumference | Screening to Three Months Post-Treatment | |
Primary | Upper Arm Firmness | Blinded Investigator Measurement of Skin Firmness | Screening to One Month Post-Treatment | |
Primary | Upper Arm Firmness | Blinded Investigator Measurement of Skin Firmness | Screening to Three Months Post-Treatment | |
Primary | Upper Arm Elasticity | Blinded Investigator Measurement of Skin Elasticity | Screening to One Month Post-Treatment | |
Primary | Upper Arm Elasticity | Blinded Investigator Measurement of Skin Elasticity | Screening to Three Months Post-Treatment | |
Primary | Physician Global Aesthetic Improvement Scale (PGAIS) | Assessment of overall change in treatment area by blinded investigator | One Month Post-Treatment | |
Primary | Physician Global Aesthetic Improvement Scale (PGAIS) | Assessment of overall change in treatment area by blinded investigator | Three Months Post-Treatment | |
Secondary | Subject Global Aesthetic Improvement Scale (SGAIS) | Assessment of overall change in treatment area by subject | One Month Post-Treatment | |
Secondary | Subject Global Aesthetic Improvement Scale (SGAIS) | Assessment of overall change in treatment area by subject | Three Months Post-Treatment | |
Secondary | Subject Satisfaction Questionnaire | Subject degree of satisfaction with results of treatment | One Month Post-Treatment | |
Secondary | Subject Satisfaction Questionnaire | Subject degree of satisfaction with results of treatment | Three Months Post-Treatment | |
Secondary | Subject Pain Score | Subject Assessment of Pain During Treatment | Day of Treatment | |
Secondary | Erythema | Treating Investigator Evaluation of Erythema | Day of Treatment | |
Secondary | Erythema | Treating Investigator Evaluation of Erythema | One Month Post-Treatment | |
Secondary | Erythema | Treating Investigator Evaluation of Erythema | Three Months Post-Treatment | |
Secondary | Edema | Treating Investigator Evaluation of Edema | Day of Treatment | |
Secondary | Edema | Treating Investigator Evaluation of Edema | One Month Post-Treatment | |
Secondary | Edema | Treating Investigator Evaluation of Edema | Three Months Post-Treatment | |
Secondary | Dyspigmentation | Treating Investigator Evaluation of Dyspigmentation | Day of Treatment | |
Secondary | Dyspigmentation | Treating Investigator Evaluation of Dyspigmentation | One Month Post-Treatment | |
Secondary | Dyspigmentation | Treating Investigator Evaluation of Dyspigmentation | Three Months Post-Treatment | |
Secondary | Ulceration | Treating Investigator Evaluation of Ulceration/Erosion | Day of Treatment | |
Secondary | Ulceration | Treating Investigator Evaluation of Ulceration/Erosion | One Month Post-Treatment | |
Secondary | Ulceration | Treating Investigator Evaluation of Ulceration/Erosion | Three Months Post-Treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06140628 -
A 28-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Completed |
NCT01713985 -
Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck
|
N/A | |
Completed |
NCT01971736 -
Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening
|
N/A | |
Completed |
NCT01708382 -
Feasibility Study: Lifting and Tightening of the Elbows
|
N/A | |
Completed |
NCT01708252 -
Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment
|
N/A | |
Completed |
NCT01713998 -
Treatment of the Face and Neck With Lower Ulthera System Energy Settings
|
N/A | |
Completed |
NCT04296201 -
Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology
|
N/A | |
Completed |
NCT06000839 -
A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)
|
N/A | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Completed |
NCT05929625 -
Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation
|
N/A | |
Terminated |
NCT01713569 -
Feasibility Study: Histological Characterization After Treatment With the Ulthera® System
|
N/A | |
Completed |
NCT01519934 -
A Retrospective Study to Evaluate the Effectiveness of the Ulthera System
|
N/A | |
Completed |
NCT05605691 -
Post-Market Lower Eyelid Treatment With Renuvion in Greece
|
N/A | |
Completed |
NCT04477187 -
Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling
|
N/A | |
Completed |
NCT05590364 -
Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands
|
N/A | |
Active, not recruiting |
NCT06243744 -
Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery
|
N/A | |
Completed |
NCT04146584 -
Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
|
Phase 2 | |
Recruiting |
NCT05750901 -
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
|
N/A | |
Completed |
NCT04721600 -
Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance
|
N/A | |
Recruiting |
NCT06157567 -
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
|
N/A |